Article written by Tala Ballouz, Epidemiology, Biostatistics, Prevention Institute, University Of Zurich, Zurich, Dominik Menges, Alexia Anagnostopoulos, Anja Domenghino, Department Of Visceral, via https://www.bmj.com on 31 May 2023
A solid understanding of trajectories and relevant outcome measures of post-covid-19 condition is required to effectively design and adequately interpret such trials.
We chose these variables because they are probably associated with being infected with SARS-CoV-2 41 and developing post-covid-19 condition.
Stacked bar plots show self-reported severity of symptoms reported to be related to covid-19 (as a proportion of all reported symptoms).
In this prospective, population based cohort, we assessed longer term recovery and symptom trajectories up to 24 months after infection of individuals who had infections with wildtype SARS-CoV-2 who were not vaccinated before infection.
In our study, we found that half of participants reported at least one symptom up to 24 months after infection.